Does time-restricted eating increase the risk of cardiovascular death?
Why I don’t put any stock in a recent “study”
Removing race as a risk factor for cardiovascular disease?
The AHA has announced a new “race-free” assessment tool, but eliminating this variable carries the potential to increase – rather than decrease – racial disparities in healthcare
Where a study on metformin and cardiovascular disease fell short – and what it can teach us
An investigation on metformin, diabetes, lipid biology, and cardiovascular disease offered little insight on any of these topics, but it illustrates common problems in scientific research
Is low-to-moderate alcohol consumption beneficial for longevity?
There is a common belief that low-to-moderate consumption of alcohol has unique health benefits. What does the evidence show?
Reassessing the relationship between alcohol intake and cardiovascular disease risk
Mendelian randomization offers clearer insights than epidemiology or randomized trials to date
Therapeutic potential and cardiovascular risks of medical cannabis
A recent study highlights concerns regarding the potential cardiovascular risks associated with using medical cannabis. A cause for alarm?
Statins: effectiveness, safety, and common myths on their role in ASCVD prevention
A review of the evidence for statins in combating heart disease
First anti-inflammatory medication approved for treatment of ASCVD
Low-dose colchicine, an anti-inflammatory drug, was recently approved by the FDA to reduce risk of cardiovascular events
A case study on the importance of taking charge of one’s own health
The personal story of a podcast listener who sought to gain a better picture of his cardiovascular health – and who saved his own life as a result.
#260 ‒ Men’s Sexual Health: why it matters, what can go wrong, and how to fix it | Mohit Khera, M.D., M.B.A., M.P.H.
“Clinicians don’t ask about it. Patients are embarrassed to ask about it. And that’s the suffering in silence.” —Mohit Khera